Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
Patients treated with radiation therapy for lung tumors can experience inflammation after treatment. This study hopes to evaluate the use of breath analysis to evaluate changes in the composition of exhaled breath in patients undergoing radiotherapy. If changes can be detected, this may ultimately serve as biomarkers for identifying patients at highest risk for radiation-induced lung injury (radiation pneumonitis).
Checked against the public recordLast updated Jul 1, 2016 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Stanford University
- Interventions being studied
- Procedure: Exhaled Breath Sampling
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Diagnosis of any type of lung tumor * Medical recommendation (independent of the study) that the patient undergo thoracic radiation therapy. Radiation therapy may be either fractionated or hypofractionated (i.e. radiosurgery) * Age \>= 18 years old * Any gender and any ethnic background will be recruited * Capable of giving written informed consent Exclusion Criteria: * Inability of giving written informed consent * Pregnancy or breast-feeding
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Stanford University School of MedicineStanford, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 1, 2016. Always confirm current availability with the study team.